GreenLight Biosciences Holdings
GRNA · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $68 | $31 | $95 | $26 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $3 | $0 | $0 | $0 |
| Total Curr. Assets | $71 | $34 | $97 | $26 |
| Property Plant & Equip (Net) | $74 | $23 | $16 | $4 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $3 | $6 | $0 | $0 |
| Total NC Assets | $77 | $29 | $17 | $4 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $149 | $63 | $114 | $31 |
| Liabilities | – | – | – | – |
| Payables | $1 | $8 | $5 | $2 |
| Short-Term Debt | $17 | $39 | $1 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $4 | $1 | $2 | $0 |
| Other Curr. Liab. | $14 | $15 | $7 | $4 |
| Total Curr. Liab. | $36 | $62 | $14 | $6 |
| LT Debt | $64 | $27 | $18 | $1 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $1 | $4 | $220 | $111 |
| Total NC Liab. | $65 | $31 | $239 | $112 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $101 | $93 | $253 | $117 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$421 | -$254 | -$141 | -$88 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $469 | $224 | $2 | $1 |
| Total Equity | $48 | -$30 | -$139 | -$87 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $149 | $63 | $114 | $31 |
| Net Debt | $12 | $35 | -$76 | -$24 |